Cargando…

Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children

With limited and low-genetic barrier drugs used for the prevention of mother-to-child transmission (PMTCT) of HIV in sub-Saharan Africa, vertically transmitted HIV-1 drug-resistance (HIVDR) is concerning and might prompt optimal pediatric strategies. The aim of this study was to ascertain HIVDR and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fokam, Joseph, Bellocchi, Maria C., Armenia, Daniele, Nanfack, Aubin J., Carioti, Luca, Continenza, Fabio, Takou, Desire, Temgoua, Edith S., Tangimpundu, Charlotte, Torimiro, Judith N., Koki, Paul N., Fokunang, Charles N., Cappelli, Giulia, Ndjolo, Alexis, Colizzi, Vittorio, Ceccherini-Silberstein, Francesca, Perno, Carlo-Federico, Santoro, Maria M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	4850
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895385/ https://www.ncbi.nlm.nih.gov/pubmed/29595649 http://dx.doi.org/10.1097/MD.0000000000010176

Ejemplares similares

Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients
por: Teto, Georges, et al.
Publicado: (2022)

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon
por: Takou, Desire, et al.
Publicado: (2019)

Switch of predicted HIV-1 tropism in treated subjects and its association with disease progression
por: Castagna, Antonella, et al.
Publicado: (2016)

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics
por: Fokam, Joseph, et al.
Publicado: (2023)

HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon
por: Mbouyap, Pretty Rosereine, et al.
Publicado: (2023)

Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon
por: Fokam, Joseph, et al.
Publicado: (2020)

The mother-to-child transmission of HIV-1 and profile of viral reservoirs in pediatric population: A systematic review with meta-analysis of the Cameroonian studies
por: Ka’e, Aude Christelle, et al.
Publicado: (2023)

Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: The EDCTP "PERFECT-study" protocol (RIA2020EF-3000)
por: Fokam, Joseph, et al.
Publicado: (2022)

Lipid Peroxidation and Total Cholesterol in HAART-Naïve Patients Infected with Circulating Recombinant Forms of Human Immunodeficiency Virus Type-1 in Cameroon
por: Teto, Georges, et al.
Publicado: (2013)

Characterisation of HIV-1 reservoirs in paediatric populations: protocol for a systematic review and meta-analysis
por: Ka’e, Aude Christelle, et al.
Publicado: (2023)

Net charge and position 22 of the V3 loop are associated with HIV-1 tropism in recently infected female sex workers in Nairobi, Kenya
por: Abisi, Hellen K, et al.
Publicado: (2022)

Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens
por: Fokam, Joseph, et al.
Publicado: (2023)

Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens
por: Fokam, Joseph, et al.
Publicado: (2023)

Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé
por: Nka, Alex Durand, et al.
Publicado: (2019)

HIV-1 Gag gene mutations, treatment response and drug resistance to protease inhibitors: A systematic review and meta-analysis protocol
por: Nka, Alex Durand, et al.
Publicado: (2021)

Assessment of T cell immune responses towards HIV-1 epitopes designed by reverse immunogenetic approach: proof-of-concept in HIV+ Cameroonian children
por: Nemes, E, et al.
Publicado: (2012)

Genotypic Prediction of Tropism of Highly Diverse HIV-1 Strains from Cameroon
por: Mbondji-Wonje, Christelle, et al.
Publicado: (2014)

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol
por: Semengue, Ezechiel Ngoufack Jagni, et al.
Publicado: (2020)

Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon
por: Fokam, Joseph, et al.
Publicado: (2020)

Challenges faced by the HIV testing system in low- and middle-income countries
por: Kamgaing, Rachel S., et al.
Publicado: (2023)

Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study)
por: Fokam, Joseph, et al.
Publicado: (2019)

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis
por: Ngoufack Jagni Semengue, Ezechiel, et al.
Publicado: (2022)

First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens
por: Fokam, Joseph, et al.
Publicado: (2020)

Human immunodeficiency virus case detection and antiretroviral therapy enrollment among children below and above 18 months old: A comparative analysis from Cameroon
por: Yumo, Habakkuk A., et al.
Publicado: (2021)

Safety of low dose efavirenz regimen in Indian adults with HIV-1 infection: Insights from a phase 4 interventional randomised trial
por: Dravid, Ameet N., et al.
Publicado: (2023)

Perinatal HIV Status and Executive Function During School-Age and Adolescence: A Comparative Study of Long-Term Cognitive Capacity Among Children From a High HIV Prevalence Setting
por: Ezeamama, Amara E., et al.
Publicado: (2016)

Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study
por: Troya, Jesús, et al.
Publicado: (2022)

Characterization of the Viral Reservoirs Among HIV-1 Non-B Vertically Infected Adolescents Receiving Antiretroviral Therapy: Protocol for an Observational and Comparative Study in Cameroon
por: Nanfack, Aubin Joseph, et al.
Publicado: (2022)

Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy
por: Torimiro, Judith N., et al.
Publicado: (2018)

Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western India
por: Karade, Santosh K., et al.
Publicado: (2016)

Effect of Dolutegravir regimen against other regimens on some hematological parameters, CD4 count and viral load of people living with HIV infection in South Eastern Nigeria
por: Echefu, Stella N., et al.
Publicado: (2023)

Immune Compromise in HIV-1/HTLV-1 Coinfection With Paradoxical Resolution of CD4 Lymphocytosis During Antiretroviral Therapy: A Case Report
por: Rockwood, N., et al.
Publicado: (2015)

Prevalence and factors associated with HIV-1 drug resistance mutations in treatment-experienced patients in Nairobi, Kenya: A cross-sectional study
por: Scriven, Yvonne A., et al.
Publicado: (2021)

Improving knowledge and perception of HIV/AIDS among English language speaking children in rural areas through educational digital storytelling
por: Dike, Ibiwari Caroline, et al.
Publicado: (2021)

Depressive and Anxiety Symptoms Predict Sustained Quality of Life Deficits in HIV-Positive Ugandan Adults Despite Antiretroviral Therapy: A Prospective Cohort Study
por: Ezeamama, Amara E, et al.
Publicado: (2016)

Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India
por: Dravid, Ameet N., et al.
Publicado: (2018)

Human papillomavirus positivity and cervical lesions in relation to HIV infection: a comparative assessment in the Cameroonian female population
por: SOSSO, SAMUEL MARTIN, et al.
Publicado: (2023)

Efficacy and safety of 400 mg efavirenz versus standard 600 mg dose when taken with tenofovir and lamivudine combination in Indian adult patients with HIV-1 infection: An open-label, interventional, randomized, non-inferiority trial
por: Dravid, Ameet, et al.
Publicado: (2022)

Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study
por: Desai, Seema N., et al.
Publicado: (2016)

Higher subcortical and white matter cerebral blood flow in perinatally HIV-infected children
por: Blokhuis, Charlotte, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2kt1v06u0gbf1e76jf067c74t8